Decellularized Carotid Artery Functions as an Arteriovenous Graft.

Abstract

BACKGROUND\nProsthetic arteriovenous grafts (AVG) continue to have a high rate of failure in clinical use, yet there is continued clinical demand for them. However, there is no small animal model of AVG to test novel tissue-engineered vascular grafts. We established a new rat arteriovenous graft model to compare the healing of decellularized carotid artery (CA) to autologous CA.\n\n\nMATERIALS AND METHODS\nThe infrarenal vena cava and aorta of Wistar rats were exposed and dissected free below renal artery. A longitudinal 1\xa0mm venotomy and arteriotomy were made on the anterior walls. The conduit was either autologous CA or heterologous decellularized CA; a conduit was sewn to the inferior vena cava and aorta in end-to-side fashion. Rats were sacrificed on postoperative day 21 for examination.\n\n\nRESULTS\nAll rats survived without heart failure. Conduits had 100% patency rate (day 21) in both the control and decellularized CA groups (n\xa0=\xa06). Both control and decellularized CA showed similar rates of reendothelialization, inflammatory cell infiltration, and cell turnover. The outflow vein beyond the autologous or decellularized conduits showed similar neointimal thickness and cell turnover.\n\n\nCONCLUSIONS\nDecellularized CA may be a viable tissue engineering graft for use as an arteriovenous graft for dialysis access. The rat aorta-vena cava graft is a useful model to test new materials including tissue-engineered grafts for use as AVG.